Specialty

Neurology

Organization

Rady Children's Specialists of San Diego

Medical Group / IPA

CPMG/RCHN/RCSSD

Medical School

University of Cincinnati College of Medicine

Internship

Children's Hospital Los Angeles

Residency

UCLA School of Medicine

Fellowship

National Institutes of Health, UCLA School of Medicine

Board Certifications

Neurology

Gender

M

Bio

Dr. Rho is the division chief of neurology at Rady Children's Hospital-San Diego and a professor of neurosciences and pediatrics at UC San Diego School of Medicine.

His clinical expertise is in general pediatric neurology and pediatric epilepsy, with an emphasis on pharmacological therapies and metabolic approaches toward epilepsy treatment, such as the ketogenic diet. His main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of the ketogenic diet and its clinical variants. Dr. Rho's research activities have been funded by grants from the National Institutes of Health, Canadian Institutes of Health Research, Brain Canada and a variety of intramural and extramural public and private sector sources.

Prior to his current position, Dr. Rho held full-time academic faculty appointments at the University of Washington (Seattle) and Seattle Children's Hospital; the University of California at Irvine; the University of Arizona and Arizona State University (Barrow Neurological Institute in Phoenix); and most recently, the Alberta Children's Hospital and the University of Calgary (Alberta, Canada).

Dr. Rho completed residency training in pediatrics at Children's Hospital Los Angeles (affiliated with the University of Southern California), followed by adult neurology and pediatric neurology residency/fellowship training at the University of California Los Angeles Medical Center (David Geffen School of Medicine at UCLA). He also completed a research fellowship in neuropharmacology at the National Institutes of Health. Dr. Rho received his undergraduate degree in molecular biophysics and biochemistry from Yale University and his medical degree from the University of Cincinnati.

Publications

Metabolism-based drug discovery in zebrafish: An emerging strategy to uncover new anti-seizure therapies.
Ibhazehiebo K, Rho JM, Kurrasch DM

Metabolic Framework for the Improvement of Autism Spectrum Disorders by a Modified Ketogenic Diet: A Pilot Study.
Mu C, Corley MJ, Lee RWY, Wong M, Pang A, Arakaki G, Miyamoto R, Rho JM, Mickiewicz B, Dowlatabadi R, Vogel HJ, Korchemagin Y, Shearer J

Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives.
Poff AM, Rho JM, D'Agostino DP

Precocious myelination in a mouse model of autism.
Khanbabaei M, Hughes E, Ellegood J, Qiu LR, Yip R, Dobry J, Murari K, Lerch JP, Rho JM, Cheng N

Position Statement on the Use of Medical Cannabis for the Treatment of Epilepsy in Canada.
Appendino JP, Boelman C, Brna PM, Burneo JG, Claassen CS, Connolly MB, De Guzman MVT, Federico P, Floyd D, Huntsman RJ, Javidan M, Jette N, Jurasek LL, Keezer MR, Lau JC, McCoy B, McLachlan RS, Ng MC, Nguyen DK, Reid AY, Rho JM, Snead OC, Téllez-Zenteno JF, Wang L, Zak MM

Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
Boison D, Rho JM

Single-center experience with Beta-propeller protein-associated neurodegeneration (BPAN); expanding the phenotypic spectrum.
Chard M, Appendino JP, Bello-Espinosa LE, Curtis C, Rho JM, Wei XC, Al-Hertani W

2-Deoxyglucose and Beta-Hydroxybutyrate: Metabolic Agents for Seizure Control.
Rho JM, Shao LR, Stafstrom CE

Enhanced glycolytic metabolism supports transmigration of brain-infiltrating macrophages in multiple sclerosis.
Kaushik DK, Bhattacharya A, Mirzaei R, Rawji KS, Ahn Y, Rho JM, Yong VW

Highlights From the Annual Meeting of the American Epilepsy Society 2018.
Jobst BC, Ben-Menachem E, Chapman KE, Fu A, Goldman A, Hirsch LJ, Jehi LE, Kossoff EH, Plueger M, Rho JM, Schevon CA, Shinnar S, Sperling MR, Simeone TA, Wagner JL, Lado F

Calcium Involved Directional Organization of Polymer Chains in Polyester Nanogranules in Bacterial Cells.
Tian B, Shah M, Choi MH, Rho JK, Lee SY, Yoon SC

Glycolytic inhibition: A novel approach toward controlling neuronal excitability and seizures.
Shao LR, Rho JM, Stafstrom CE

Brief history of anti-seizure drug development.
Rho JM, White HS

Altered circadian rhythms and oscillation of clock genes and sirtuin 1 in a model of sudden unexpected death in epilepsy.
Wallace E, Wright S, Schoenike B, Roopra A, Rho JM, Maganti RK

Infantile Epileptic Encephalopathy With Multiple Genetic Mutations: How Important are Variants of Undetermined Significance?
Almomen M, Rho JM, Scantlebury MH

Metabolism and epilepsy: Ketogenic diets as a homeostatic link.
Masino SA, Rho JM

Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.
Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina Bergqvist AG, Blackford R, Buchhalter JR, Caraballo RH, Cross JH, Dahlin MG, Donner EJ, Guzel O, Jehle RS, Klepper J, Kang HC, Lambrechts DA, Liu YMC, Nathan JK, Nordli DR Jr, Pfeifer HH, Rho JM, Scheffer IE, Sharma S, Stafstrom CE, Thiele EA, Turner Z, Vaccarezza MM, van der Louw EJTM, Veggiotti P, Wheless JW, Wirrell EC, Charlie Foundation., Matthew's Friends., Practice Committee of the Child Neurology Society.

Comorbid epilepsy in autism spectrum disorder: Implications of postnatal inflammation for brain excitability.
Lewis ML, Kesler M, Candy SA, Rho JM, Pittman QJ

The relationship between d-beta-hydroxybutyrate blood concentrations and seizure control in children treated with the ketogenic diet for medically intractable epilepsy.
Buchhalter JR, D'Alfonso S, Connolly M, Fung E, Michoulas A, Sinasac D, Singer R, Smith J, Singh N, Rho JM

Electrophysiological characterization of a mitochondrial inner membrane chloride channel in rat brain.
Drummond-Main CD, Rho JM

A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.
Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma SC, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim DY, Rho JM, Kurrasch DM

Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?
Simeone TA, Simeone KA, Stafstrom CE, Rho JM

ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction.
Lopes F, Keita ÅV, Saxena A, Reyes JL, Mancini NL, Al Rajabi A, Wang A, Baggio CH, Dicay M, van Dalen R, Ahn Y, Carneiro MBH, Peters NC, Rho JM, MacNaughton WK, Girardin SE, Jijon H, Philpott DJ, Söderholm JD, McKay DM

Ketogenic diet-induced extension of longevity in epileptic Kcna1-null mice is influenced by gender and age at treatment onset.
Chun KC, Ma SC, Oh H, Rho JM, Kim DY

Radiolabeling and preliminary biodistribution study of <sup>99m</sup>Tc-labeled antibody-mimetic scaffold protein repebody for initial clearance properties.
Mushtaq S, Rho JK, Kang JA, Lee JJ, Kim JY, Nam YR, Yun SJ, Lee GH, Park SH, Lee DE, Kim HS

See the full listing of this physician's publications on PubMed, a service of the National Library of Medicine.

PubMed is a third-party website and not affiliated with Rady Children's Hospital-San Diego.

Rady Children's updates the Doctor Finder annually. We are not responsible for omissions or errors. Prior to making an appointment, please be sure to check with your health plan to confirm coverage. If you see an error or omission on a physician's profile page, please contact us at refsvc@rchsd.org.